Neuberger Berman Group LLC Inovio Pharmaceuticals, Inc. Transaction History

Neuberger Berman Group LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$6.23 - $10.03 $105,206 - $169,376	-16,887 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$9.57 - $27.05 $156,469 - $442,267	-16,350 Reduced 49.19%	16,887 $195,000
Q2 2020 Aug 13, 2020	SELL	$7.14 - $31.69 $119,587 - $530,775	-16,749 Reduced 33.51%	33,237 $896,000
Q1 2020 May 14, 2020	SELL	$2.98 - $14.09 $19,072 - $90,176	-6,400 Reduced 11.35%	49,986 $371,000
Q3 2019 Nov 13, 2019	BUY	$2.05 - $3.02 $102 - $151	50 Added 0.09%	56,386 $116,000

Q2 2019 Aug 13, 2019	BUY	$2.29 - $4.1 $70,385 - $126,017	30,736 Added 120.06%	56,336 $166,000
Q4 2018 Feb 12, 2019	BUY	$3.89 - $6.11 $99,584 - $156,416	25,600 New	25,600 $102,000
Q3 2018 Nov 13, 2018	SELL	$3.92 - $5.58 $136,094 - $193,726	-34,718 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$3.88 - $5.16 $2,328 - $3,096	600 Added 1.76%	34,718 $136,000
Q4 2017 Feb 14, 2018	BUY	$4.13 - $6.68 $65,873 - $106,546	15,950 Added 87.79%	34,118 $141,000
Q3 2017 Nov 15, 2017	BUY	$5.36 - $6.37 $97,380 - $115,730	18,168	18,168 $115,000

292K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $2.02B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.